ALEXANDRIA, Va., Dec. 31 -- United States Patent no. 12,508,251, issued on Dec. 30, was assigned to NATIONAL UNIVERSITY CORPORATION KUMAMOTO UNIVERSITY; (Kumamoto, Japan), NATIONAL UNIVERSITY CORPORATION TOKYO MEDICAL AND DENTAL UNIVERSITY (Tokyo) and JAPAN AS REPRESENTED BY DIRECTOR-GENERAL OF NATIONAL INSTITUTE OF INFECTIOUS DISEASES (Tokyo).
"CD4 mimic compound with anti-HIV activity" was invented by Shuzo Matsushita (Kumamoto, Japan), Kazuhisa Yoshimura (Kumamoto, Japan), Hirokazu Tamamura (Tokyo), Ami Masuda (Tokyo), Kohei Takahashi (Tokyo), Takuya Kobayakawa (Tokyo), Shigeyoshi Harada (Tokyo) and Tomoyuki Miura (Kyoto, Japan).
According to the abstract* released by the U.S. Patent & Trademark Office: "CD4 mimic compounds having impr...